🕵️ Alamar Biosciences, Inc. ($ALMR)
SEC insider & ownership activity, last 12 months · CIK 2104204 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
2 buyers, value withheld pending verification (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Illumina Innovation Fund II GP, L.L.C. | 1 | value withheld pending verification | 0 | – | Apr 20, 2026 |
| Naclerio Nicholas | 1 | value withheld pending verification | 0 | – | Apr 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd | 10.2% | 13G | Aug 11, 2026 | filing ↗ | |
| Qiming Venture Partners VI, L.P. | 9.9% | 13G | Aug 11, 2026 | filing ↗ | |
| Nicholas Naclerio | 9.6% | 13D | Apr 20, 2026 | filing ↗ | |
| Illumina Innovation Fund II GP, L.L.C. | 8.8% | 13D | Apr 20, 2026 | filing ↗ | |
| Illumina Innovation Fund II, L.P. | 8.8% | 13D | Apr 20, 2026 | filing ↗ | |
| Daqing Cai | 7.2% | 13G | Jul 2, 2026 | filing ↗ | |
| Yuling Luo | 6.4% | 13G | Aug 13, 2026 | filing ↗ | |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 6.1% | 13D | Jul 5, 2026 | filing ↗ | |
| Sands Capital Alternatives, LLC | 6.1% | 13D | Jul 5, 2026 | filing ↗ | |
| Frank M. Sands | 6.1% | 13D | Jul 5, 2026 | filing ↗ | |
| Sherpa Healthcare Fund II, L.P. | 5.7% | 13G | Jul 2, 2026 | filing ↗ | |
| Sherpa Healthcare Fund II GP, Ltd. | 5.7% | 13G | Jul 2, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 28, 2026 | filing ↗ |
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Jul 15, 2026 | filing ↗ |
| Earnings (2.02) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |